Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Companies Social issues Health care industry
From CNBC.com News
Europe's pharma industry braces for tariffs as carve-out hopes fade
Tags LILLY DRN Health & Science Biotechnology
From CNBC.com News
Hims & Hers shares rise as company adds new weight-loss medications to platform
Tags Health & Science Hims & Hers Health Inc Breaking News: Technology
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Biotech and Pharmaceuticals Breaking News: Markets Johnson & Johnson
From CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Tags Health & Science LILLY DRN Merck & Co Inc
From CNBC.com News
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Tags Health & Science Social issues Business
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Companies Health care industry LILLY DRN
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Biotechnology Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags LILLY DRN Science Health & Science
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Economy Business News Technology
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags LILLY DRN US: News Health & Science
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
Tags China Markets PepsiCo Inc/ China Politics
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Business News Breaking News: Business Pharmaceuticals
From CNBC.com News
Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate
Tags Pharmaceuticals LILLY DRN Biotech and Pharmaceuticals
From CNBC.com News
White House: Stock market plunge is not as 'meaningful' as business activity
Tickers CEOS
Tags Taiwan Semiconductor Manufacturing Co Ltd Nasdaq Inc Elections
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Business Biotechnology Health & Science
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Health care industry Companies Novo Nordisk A/S
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Amazon/com Inc Novo Nordisk A/S Structure Therapeutics Inc
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Companies Health care industry Biotechnology
From CNBC.com News
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Tags LILLY DRN US: News Health & Science
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Health care industry Companies Hims & Hers Health Inc
From CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
Tags Science Biotech and Pharmaceuticals LILLY DRN
From CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
Tags Health & Science Health care industry Amgen Inc
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Deere & Co U/S/ Economy World economy
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Amazon/com Inc Business News Earnings
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Companies Health care industry Health & Science
From CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
Tags Companies Health care industry Biotechnology
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.